canada
No description yet: the sentence for this tag has not been written. 5 records carry it: 5 people.
Related tags
5 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Joseph M. Connors Clinical Professor Emeritus, BC Cancer Centre for Lymphoid Cancer, University of British Columbia · BC Cancer Led ECHELON-1, which replaced bleomycin with brentuximab vedotin in first-line advanced Hodgkin lymphoma. | Hodgkin lymphoma | none | hodgkin, adc | ||
Kim N. Chi Medical Oncologist and Chief Medical Officer, BC Cancer; Professor, University of British Columbia · BC Cancer Led TITAN and MAGNITUDE, bringing apalutamide to hormone-sensitive disease and niraparib to HRR-mutant prostate cancer. | Prostate cancer | none | prostate, trialist | ||
Laurie H. Sehn Chair, Lymphoma Tumour Group, BC Cancer; Clinical Professor, University of British Columbia · BC Cancer Lymphoma specialist who wrote the definitive DLBCL review and helped establish polatuzumab and other new agents. | Diffuse large B-cell lymphoma | none | lymphoma, outcomes | ||
Simron Singh Medical Oncologist and Co-Director, Susan Leslie Clinic for Neuroendocrine Tumours, Sunnybrook Odette Cancer Centre · Sunnybrook Odette Cancer Centre Led NETTER-2, which moved lutetium dotatate into first-line treatment of higher-grade neuroendocrine tumours. | Neuroendocrine tumours | none | neuroendocrine, radioligand | ||
Timothy J. Whelan Professor of Oncology, McMaster University; Radiation Oncologist, Juravinski Cancer Centre · Juravinski Cancer Centre / Escarpment Cancer Research Institute Led the Canadian trials that established three-week breast radiotherapy and defined when nodal radiotherapy helps. | HR-positive / HER2-negative breast cancer | none | radiotherapy, breast |
